Pharmacology Flashcards
(298 cards)
What are the types and effects of adrenergic receptors?
Stimulate alpha-1 and beta-1 receptors.
Inhibit alpha-2 and beta-2 receptors.
What do alpha-1 receptors work on?
Alpha 1 receptors are adrenergic receptors.
GQ protein coupled to produce stimulatory effect
Found in:
- blood vessels –> Vasoconstriction
Certain smooth muscles of urogenital tract –> contraction e.g. oppose voiding bladder and ejactulation.
- glands –> secretion
- GI tract –> relaxation
Agonist: phenylephrine
Antagonist: prazosin
What do beta-1 receptors work on?
Found in:
- Heart
SA note –> increase rhythmicity increase heart rate
AV node –> increase conduction velocity
ventricular myocytes –> increase contractility
- Juxtaglomerular cells in kidneys –> increase renin release
Selective agonist: Dobutamine
Selective antagonist: metoprolol, atenolol, etc
What do Beta 2 receptors act on?
Found in:
Bronchi –> Bronchodilation
Blood Vessels –> vasodilation
uterus –> relaxation
GI tract –> relaxation
Pancreas –> glucagon secretion
Eye –> increase aqueous secretion
Detrusor muscle –> relaxation
Selective agonist: Salbutamol, terbutaline
Selective antagonist: alpha-methyl propanolol
What do beta 3 receptors act on?
Found in adipose tissue and detrusor muscle to cause relaxation
Selective agonist: mirabegron
What are the effects of the dopamine and its receptors when stimulated?
Dopamine is a catecholamine that has mixed adrenergic effects.
It has little alpha-adrenergic effects
lower doses (0.5-3mcg/kg/min): Dilate renal mesenteric coronary vascular beds. Useful in oliguric renal failure.
higher doses (5-13 mcg/kg/min): has beta-1 adrenergic agonist affects resulting in vasodilation. Can be used to improve cardiac output by decreasing afterload.
Dose range: 1-20mcg/kg/min. Discontinue if tachycardic or arrhythmic.
What are the effects of norepinephrine?
Norepinephrine is a mixed adrenergic agonist with a stronger effect on alpha-1 receptors than beta receptors.
It causes increased vasoconstriction.
It will commonly lower heart rate on account of baroreceptor reflex with increased blood pressure
Caution: Large dose of norepinephrine can cause profound bradycardia
Concern: to much vasoconstriction increases afterload causing decreased cardiac output.
Dose: 0.1 - 2mcg/kg/min
What are the effects of phenylephrine?
Phenylephrine is an alpha-1 agonist.
Indicated for hypotension when beta-adrenergic agonist effects are not desirable.
Can cause increased blood pressure and bradycardia.
too much vasoconstriction can increase afterload and decrease output. (Use with caution in patient with bradycardia or cardiac disease).
Dose: 0.1-2mcg/kg/min
What are the effects of vasopressin?
Vasopressin is also known as anti-diuretic hormone.
It causes vasoconstriction independent of adrenergic stimulation.
It is commonly used in conjunction with norepinephrine for refractory hypotension.
Vasopressin is not affected by pH making it ideal for use during prolonged CPR.
Dose: 0.01-0.04units/kg/min
Strength: 0.01units/ml
What are the effects of epinephrine?
Epinephrine is a mixed adrenergic agonist with both alpha 1 and beta one agonist properties
Low dose: beta-adrenergic effects predominate improving cardiac output and cardiac contractility
higher doses: more of an alpha-1 adrenergic agonist resulting in vasoconstriction.
CRI dose: 0.1-2.0mcg/kg/min
What do alpha-2 receptors work on?
Gi/Go coupled proteins acting on adenylyl cyclase cAMP pathway to produce inhibitory effects
receptors located prejunctional in nerve endings to inhibit transmitter release
Receptors in the brain decrease sympathetic flow
receptors in the pancreatic beta cells inhibit the release of insulin
Alpha 2 promotes platelet aggregation
receptors in the blood vessels induces vasoconstriction
results in profound sedative and analgesic qualities. Alpha-2 are effective emetics in cats
Agonist: Clonidine, dexmeditomidine, xylazine
Antagonist: Yohimbine
Cholinergic Muscarinic receptors
Involved in peristalsis, micturition, bronchoconstriction and several other parasympathetic reactions.
Muscarinic receptors are type of ligand-gated G-protein coupled receptor and are linked to second messenger systems.
Muscarinic receptor varies with the receptor subtype.
These receptors occur in the CNS and the autonomic parasympathetic division of the PNS.
Cholinergic receptors
Two types of cholinergic receptors: Nicotinic and muscarinic
Cholinergic nicotinic receptors
Found on skeletal muscles in the autonomic division of the peripheral nervous system and in the central nervous system.
Nicotinic receptors are monovalent cation channels through which both sodium and potassium can pass.
Nicotinic receptors divided into two subtypes:
N1 - peripheral neuromuscular junction - muscle contraction, if on adrenal glands - release adrenaline and norepinephrine
N2 - central nervous systemor neuronal
Adrenergic receptors
Are divided into two classes (alpha and beta) with multiple subtypes each.
Adrenergic receptors are linked to G proteins and initiate a second messenger cascade.
Glutaminergic Receptors
Metabotropic glutaminergic receptors act through G-protein-coupled receptors. Two types of glutaminergic receptors are receptor channels.
Glutamate
The main excitatory neurotransmitter in the CNS and also acts as a neuromodulator.
Action of glutamate at a particular synapse depends on which of its receptor types occurs on the target cell
alpha amino-3-hydroxy-5 methylisoxazole-4-proprionic acid)
AMPA receptors
Ligand-gated monovalent cation channels are similar to nicotinic acetylcholine channels.
Glutamate binding opens the channel, and the cell depolarizes due to net sodium influx.
N-methyl-D-aspartate
NMDA receptors
cation channels that allow sodium, potassium, and calcium to pass through the channel
Channel opening requires both glutamate binding and a change in membrane potential.
NMDA receptor channel is blocked by magnesium ions at resting membrane potentials.
Glutamate binding opens the ligand-activated gate, but ions cannot flow past the magnesium. If the cell depolarizes, the magnesium blocking the channel is expelled, and ions flow through the pores.
The NMDA receptor is a CNS receptor that ultimately has an excitatory effect CNS effect. Activation of NMDA receptors has been associated with altered modulation pathways and the formation of chronic pain including hyperalgesia, allodynia and reduced functionality of opioid receptors.
Ketamine is believed to be an NMDA antagonist that essentially shus off the NMDA receptor and believed to prevent and treat hyperalgesia and allodynia.
Hyperalgesia
phenomenon resulting in prolonged exposure of receptors to noxious stimuli, leading to stimulus that should cause mild pain producing an excessive sense of pain.
allodynia
a type of nerve pain that causes pain from stimuli that normally wouldn’t cause pain. e.g. a mild stimulus may feel more painful when sunburned or inflammed.
Gamma-aminobutyric acid type A (GABA A)
Ligand-gated ion channels that allow chloride ions to pass into cells.
one of the body’s main inhibitory transmitters. When stimulated will suppress excitability in the central nervous system.
Drugs that stimulate GABA A receptors: Avermectins, Benzodiazepines, propofol, Etomidate, Alfaxalone
Conditions that increase activity of GABA system: hepatic encephalopathy
Drugs that will decrease GABA: Metaldhyde, Lead interferes with GABA
What does ACEi stand for? What does it do?
Angiotensin-converting enzyme inhibitors that disrupt the renin-angiotensin-aldosterone system (RAAS).
Which organs does angiotensin II act on and what is the outcome of its mechanism of action?
Converted from Angiotensin I by angiotensin-converting enzyme (ACE)
Angiotensin II is a hormone that binds to receptors in various tissues to exert various effects.
Acts on the adrenal cortex, causing it to release aldosterone.
stimulates vasoconstriction in systemic arterioles
Promotes sodium reabsorption in proximal convoluted tubules of the kidneys.
In the CNS:
It acts on the hypothalamus to stimulate thirst and encourage water intake
It induces the posterior pituitary to release antidiuretic hormone
It reduces the sensitivity of the baroreceptors’ response to increase blood pressure